Methylenetetrahydrofolate Reductase C677T Distribution among Cervical Cancer Patients at Dr. Hasan Sadikin General Hospital

Cervical cancer is the second most common cancer among women in the world. Persistent infection with high risk human papillomavirus (HPV) is one of the necessary causes of cervical cancer development. However, host genetic factors may also play a role in cervical cancer carcinogenesis. Methylenetetr...

Full description

Bibliographic Details
Main Authors: Ani Melani Maskoen, Cynthia Kurniawan, Herman Susanto, Edhyana Sahiratmadja
Format: Article
Language:English
Published: Universitas Padjajaran 2016-12-01
Series:Majalah Kedokteran Bandung
Subjects:
Online Access:http://journal.fk.unpad.ac.id/index.php/mkb/article/view/754
_version_ 1819154901635170304
author Ani Melani Maskoen
Cynthia Kurniawan
Herman Susanto
Edhyana Sahiratmadja
author_facet Ani Melani Maskoen
Cynthia Kurniawan
Herman Susanto
Edhyana Sahiratmadja
author_sort Ani Melani Maskoen
collection DOAJ
description Cervical cancer is the second most common cancer among women in the world. Persistent infection with high risk human papillomavirus (HPV) is one of the necessary causes of cervical cancer development. However, host genetic factors may also play a role in cervical cancer carcinogenesis. Methylenetetrahydrofolate reductase enzyme, encoded by the MTHFR gene, regulates folate metabolism which is important for genetic expression and stability. Single nucleotide polymorphism (SNP) C677T in MTHFR gene may produce a thermo-labile enzyme, resulting in a reduced enzyme activity. The aim of this study was to explore the SNP C677T of MTHFR gene and the susceptibility to cervical cancer among cancer patients visiting Dr. Hasan Sadikin General Hospital, Bandung, Indonesia. This descriptive quantitative study involved cervical cancer patients recruited in 2010 and their control group. Genomic DNA was extracted from patients’ blood. MTHFR C677T genotype was performed using BeadXpress Reader Illumina® and some samples were re-genotyped for confirmation using conventional PCR-RFLP. The distribution of MTHFR C677T genotype in cervical cancer patients was 71.6%, 25.4%, and 3%, and 44%, 36%, and 20% in control group for CC, CT, and TT, respectively. This yielded a statistical significant difference of CC vs CT+TT (p 0.014 with OR 3.22 and CI 95% 1.24 – 8.33). Taken together, this result indicates that T allele has a protective effect against cervical cancer development. Further studies to confirm this effect in bigger population is warranted. [MKB. 2016;48(4):216–21]
first_indexed 2024-12-22T15:28:27Z
format Article
id doaj.art-fbe20e7cd320434eab04e37ac10c723f
institution Directory Open Access Journal
issn 0126-074X
2338-6223
language English
last_indexed 2024-12-22T15:28:27Z
publishDate 2016-12-01
publisher Universitas Padjajaran
record_format Article
series Majalah Kedokteran Bandung
spelling doaj.art-fbe20e7cd320434eab04e37ac10c723f2022-12-21T18:21:26ZengUniversitas PadjajaranMajalah Kedokteran Bandung0126-074X2338-62232016-12-01484216221Methylenetetrahydrofolate Reductase C677T Distribution among Cervical Cancer Patients at Dr. Hasan Sadikin General HospitalAni Melani MaskoenCynthia KurniawanHerman SusantoEdhyana SahiratmadjaCervical cancer is the second most common cancer among women in the world. Persistent infection with high risk human papillomavirus (HPV) is one of the necessary causes of cervical cancer development. However, host genetic factors may also play a role in cervical cancer carcinogenesis. Methylenetetrahydrofolate reductase enzyme, encoded by the MTHFR gene, regulates folate metabolism which is important for genetic expression and stability. Single nucleotide polymorphism (SNP) C677T in MTHFR gene may produce a thermo-labile enzyme, resulting in a reduced enzyme activity. The aim of this study was to explore the SNP C677T of MTHFR gene and the susceptibility to cervical cancer among cancer patients visiting Dr. Hasan Sadikin General Hospital, Bandung, Indonesia. This descriptive quantitative study involved cervical cancer patients recruited in 2010 and their control group. Genomic DNA was extracted from patients’ blood. MTHFR C677T genotype was performed using BeadXpress Reader Illumina® and some samples were re-genotyped for confirmation using conventional PCR-RFLP. The distribution of MTHFR C677T genotype in cervical cancer patients was 71.6%, 25.4%, and 3%, and 44%, 36%, and 20% in control group for CC, CT, and TT, respectively. This yielded a statistical significant difference of CC vs CT+TT (p 0.014 with OR 3.22 and CI 95% 1.24 – 8.33). Taken together, this result indicates that T allele has a protective effect against cervical cancer development. Further studies to confirm this effect in bigger population is warranted. [MKB. 2016;48(4):216–21]http://journal.fk.unpad.ac.id/index.php/mkb/article/view/754MTHFR C677TpolymorphismBandungCervical cancerBandung
spellingShingle Ani Melani Maskoen
Cynthia Kurniawan
Herman Susanto
Edhyana Sahiratmadja
Methylenetetrahydrofolate Reductase C677T Distribution among Cervical Cancer Patients at Dr. Hasan Sadikin General Hospital
Majalah Kedokteran Bandung
MTHFR C677T
polymorphism
Bandung
Cervical cancer
Bandung
title Methylenetetrahydrofolate Reductase C677T Distribution among Cervical Cancer Patients at Dr. Hasan Sadikin General Hospital
title_full Methylenetetrahydrofolate Reductase C677T Distribution among Cervical Cancer Patients at Dr. Hasan Sadikin General Hospital
title_fullStr Methylenetetrahydrofolate Reductase C677T Distribution among Cervical Cancer Patients at Dr. Hasan Sadikin General Hospital
title_full_unstemmed Methylenetetrahydrofolate Reductase C677T Distribution among Cervical Cancer Patients at Dr. Hasan Sadikin General Hospital
title_short Methylenetetrahydrofolate Reductase C677T Distribution among Cervical Cancer Patients at Dr. Hasan Sadikin General Hospital
title_sort methylenetetrahydrofolate reductase c677t distribution among cervical cancer patients at dr hasan sadikin general hospital
topic MTHFR C677T
polymorphism
Bandung
Cervical cancer
Bandung
url http://journal.fk.unpad.ac.id/index.php/mkb/article/view/754
work_keys_str_mv AT animelanimaskoen methylenetetrahydrofolatereductasec677tdistributionamongcervicalcancerpatientsatdrhasansadikingeneralhospital
AT cynthiakurniawan methylenetetrahydrofolatereductasec677tdistributionamongcervicalcancerpatientsatdrhasansadikingeneralhospital
AT hermansusanto methylenetetrahydrofolatereductasec677tdistributionamongcervicalcancerpatientsatdrhasansadikingeneralhospital
AT edhyanasahiratmadja methylenetetrahydrofolatereductasec677tdistributionamongcervicalcancerpatientsatdrhasansadikingeneralhospital